atorvastatin
Lipitor (atorvastatin) is a statin that lowers LDL cholesterol by slowing its production in the liver and helping clear it from the blood. Beyond lowering numbers, it reduces the risk of heart attack and stroke in people with cardiovascular risk factors or established heart disease.
This page is based on the FDA label for atorvastatin, cross-checked with MedlinePlus and the National Cancer Institute dictionary; the mechanism is explained in plain language, and analogies are used only where they stay accurate.
How it works
Explains what the medicine does in the body, not dosing, side effects, or safety.
An analogy
The liver is a factory that manufactures cholesterol around the clock, and HMG-CoA reductase is the foreman of the production line. Atorvastatin sends the foreman home, so the factory slows output; sensing the shortage, the liver pulls more cholesterol out of the bloodstream to keep itself supplied, and blood levels fall.
In simple terms
Most cholesterol in the blood is made by the liver. Atorvastatin blocks HMG-CoA reductase, the enzyme the liver needs to produce cholesterol. When the liver makes less, it responds by capturing more LDL cholesterol from the blood, which lowers the level that can build up in artery walls. This is why statins reduce heart attacks and strokes, not just cholesterol numbers.
In depth
Atorvastatin competitively inhibits hepatic HMG-CoA reductase, the enzyme catalysing the conversion of HMG-CoA to mevalonate, the committed step in sterol biosynthesis. Reduced intrahepatic cholesterol triggers upregulation of LDL receptors via SREBP-2, increasing LDL uptake and catabolism and lowering circulating LDL particles. Atorvastatin also modestly lowers triglycerides and raises HDL cholesterol, and pleiotropic effects on endothelial function and vascular inflammation may contribute to cardiovascular protection.
See it in motion
A schematic animation of the mechanism — simplified for clarity, not drawn to scale.
How atorvastatin lowers LDL cholesterol via HMG-CoA reductase and SREBP-2
- Most cholesterol in the blood is made by the liver. Atorvastatin blocks HMG-CoA reductase, the enzyme the liver needs to produce cholesterol.
- Atorvastatin competitively inhibits hepatic HMG-CoA reductase, the enzyme catalysing the conversion of HMG-CoA to mevalonate, the committed step in sterol biosynthesis.
- Reduced intrahepatic cholesterol triggers upregulation of LDL receptors via SREBP-2, increasing LDL uptake and catabolism and lowering circulating LDL particles.
- Atorvastatin also modestly lowers triglycerides and raises HDL cholesterol, and pleiotropic effects on endothelial function and vascular inflammation may contribute to cardiovascular protection.
Target: HMG-CoA reductase
The rate-limiting enzyme of cholesterol synthesis in the liver; its product feeds the pathway that ends in cholesterol, so inhibiting it lowers the liver's cholesterol output.
Approved uses
Approved uses differ by country and change over time. Always follow your local prescribing information.
Approved uses in United States
FDA- To reduce the risk of myocardial infarction, stroke, revascularization procedures and angina in adults with multiple risk factors for coronary heart disease but without clinically evident disease
- To reduce the risk of myocardial infarction and stroke in adults with type 2 diabetes mellitus and multiple risk factors for coronary heart disease but without clinically evident disease
- To reduce the risk of non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure and angina in adults with clinically evident coronary heart disease
- As an adjunct to diet, to reduce elevated LDL cholesterol in adults with primary hyperlipidemia and in pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH)
Official sources
The statements on this page trace back to these records.
- U.S. Food and Drug Administration: atorvastatin prescribing information
U.S. Food and Drug Administration
- MedlinePlus: atorvastatin
MedlinePlus, U.S. National Library of Medicine
- National Cancer Institute: atorvastatin calcium
National Cancer Institute
This page explains how the medicine works — it isn’t the patient leaflet. For anything that applies to you, read the leaflet that came with your medicine or ask your pharmacist.
MedUnfold provides educational content and is not medical advice. Always follow your local prescribing information and healthcare professional.